ther

JANS Article

Efficacy of Dual Antiplatelet Therapy for Three Months Versus 12 months After Coronary Artery Bypass Grafting: Multicentre, Double Blinded, Randomised Controlled Trial

June 11, 2026 | Vincent SierSilver Contributor

In this article regarding the outcomes of the timing of platelet inhibition after coronary artery bypass grafting (TOP-CABG trial), the authors tested whether three months of ticagrelor-based dual antiplatelet therapy (DAPT) after elective CABG with...

ADVERTISE ON CTSNET